title: Up-regulation of VLDL receptor expression and its signaling pathway induced by VLDL and beta-VLDL.
abstract: Very low density lipoprotein receptor (VLDLR) is thought to participate in the pathogenesis of atherosclerosis induced by VLDL and beta-VLDL. The present study was undertaken to elucidate the effects of VLDL and beta-VLDL on VLDLR expression and its signaling pathway. RAW264.7 cells were incubated with VLDL and beta-VLDL. The expression of VLDLR mRNA was detected by RT-PCR. The transcriptional activity of VLDLR gene was detected in recombinant plasmid pGL4.2VR-luciferase transfected RAW264.7. Western blot assay was used to detect the changes of phosphorylated ERK1/2 protein. Inhibitors or activators were used to observe the signal pathway involving VLDLR expression regulation. The results showed that VLDL and beta-VLDL stimulated ERK1/2 activity in a PKC-dependent manner. VLDL or beta-VLDL-induced VLDLR expression on macrophages was extremely abolished by inhibitors ERK1/2 or PKC. Our findings revealed that VLDL or beta-VLDL-induced VLDLR expression via PKC/ERK cascades and the effect was linked to the transcriptional activation of VLDLR gene promoter.
authors.affiliation: Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. zhiguo_l@126.com
authors.forename: Zhiguo
authors.initials: Z
authors.lastname: Liu
authors.forename: He
authors.initials: H
authors.lastname: Li
authors.forename: Yinghong
authors.initials: Y
authors.lastname: Li
authors.forename: Yan
authors.initials: Y
authors.lastname: Wang
authors.forename: Yiqiang
authors.initials: Y
authors.lastname: Zong
authors.forename: Youmei
authors.initials: Y
authors.lastname: Feng
authors.forename: Zongchen
authors.initials: Z
authors.lastname: Feng
authors.forename: Yaozu
authors.initials: Y
authors.lastname: Deng
authors.forename: Shen
authors.initials: S
authors.lastname: Qu
mesh_terms: D002460:Cell Line; D015243:Cholesterol, VLDL / Q000494:pharmacology*; D006801:Humans; D053419:Lipoproteins, IDL / Q000494:pharmacology*; D008264:Macrophages / Q000166:cytology / Q000378:metabolism*; D019950:Mitogen-Activated Protein Kinase 1 / Q000378:metabolism; D011401:Promoter Regions, Genetic; D011493:Protein Kinase C / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D011973:Receptors, LDL / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction; D014162:Transfection; D015854:Up-Regulation
chemical_list: D015243:Cholesterol, VLDL; D053419:Lipoproteins, IDL; D012333:RNA, Messenger; D011973:Receptors, LDL; C036053:VLDL receptor; D011493:Protein Kinase C; C535150:MAPK1 protein, human; D019950:Mitogen-Activated Protein Kinase 1